Treatment with Imetelstat Improves Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in Patients with Relapsed or Refractory Higher-Risk Myelofibrosis
Year: 2020
Type: article
Source: Blood
Authors: Jean-Jacques Kiladjian, John Mascarenhas, Rami S. Komrokji, Michele Cavo, Bruno Martino, Dietger Niederwieser, Andreas Reiter, Bart L. Scott, Maria R. Baer, Ronald Hoffman, Olatoyosi Odenike, Laurie Sherman, Souria Dougherty, Faye Feller, Fei Huang, Aleksandra Rizo, Libo Sun, Ying Wan, Alessandro M. Vannucchi
Institutions: Université Paris Cité, Hôpital Saint-Louis, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Moffitt Cancer Center, University of Bologna, Azienda ospedaliera "Bianchi-Melacrino-Morelli", University Hospital Leipzig, University Medical Centre Mannheim, Fred Hutch Cancer Center, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Chicago, Geron (United States), University of Florence
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096168393